The Diabetes Virus Detection and Intervention Trial
Status:
Completed
Trial end date:
2020-10-25
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled study in 96 children and adolescents age 6-15
newly diagnosed with type 1 diabetes to describe the influence of antiviral treatment
(Pleconaril and Ribavirin) on progression of disease and residual insulin secretion.